Jackson Scott Thomas
Known title: DirectorCIK: 0001566617
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
MGNX mentioned in medical stock sector review. MacroGenics was included in a recent Yahoo Finance article examining the performance of medical stocks this year. The stock is currently trading near its 52-week low, with technical indicators showing weakness near key support levels. This context highlights the broader sector trends affecting the company's valuation.
Transaction History
| SPRO | ▲ Buy | Grant | 10,000 | $0 | 6/23/2026 | View on chart |
| MGNX | ▲ Buy | Option Exercise | 3,750 | — | 5/18/2026 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 6/12/2025 | View on chart |
| MGNX | ▲ Buy | Option Exercise | 6,500 | — | 5/20/2025 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 5/29/2024 | View on chart |
| MGNX | ▲ Buy | Option Exercise | 4,500 | $0 | 5/20/2024 | View on chart |
| SPRO | ▲ Buy | Grant | 20,000 | $0 | 10/5/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 15,000 | $0 | 9/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
SPRO among stocks that gapped in Tuesday's session
Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.
SPRO among stocks that gapped in Tuesday's session. Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.